A REVIEW OF PIONEERING ADVANCES

Vascular thrombosis, a vital medical concern, demands prompt removing of blood clots to restore blood movement. A standard intervention tactic is intravenous infusion of tissue plasminogen activator (tPA), but its limited half-life and susceptibility to inactivation by inhibitors pose troubles, leading to superior doses that cause bleeding hazards.